Pacifica Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64K | Hold |
24
| – | – | ﹤0.01% | 485 |
|
|
2025
Q1 | $1.61K | Buy |
+24
| New | +$1.61K | ﹤0.01% | 461 |
|
|
2023
Q4 | – | Sell |
-480
| Closed | -$43.2K | – | 566 |
|
|
2023
Q3 | $43.2K | Hold |
480
| – | – | 0.02% | 206 |
|
|
2023
Q2 | $38.4K | Hold |
480
| – | – | 0.02% | 187 |
|
|
2023
Q1 | $38.1K | Sell |
480
-450
| -48% | -$35.7K | 0.02% | 192 |
|
|
2022
Q4 | $62K | Hold |
930
| – | – | 0.04% | 144 |
|
|
2022
Q3 | $46K | Sell |
930
-126
| -12% | -$6.23K | 0.03% | 169 |
|
|
2022
Q2 | $58K | Buy |
1,056
+930
| +738% | +$51.1K | 0.04% | 163 |
|
|
2022
Q1 | $7K | Hold |
126
| – | – | ﹤0.01% | 343 |
|
|
2021
Q4 | $6K | Hold |
126
| – | – | ﹤0.01% | 353 |
|
|
2021
Q3 | $6K | Hold |
126
| – | – | ﹤0.01% | 347 |
|
|
2021
Q2 | $5K | Buy |
+126
| New | +$5K | ﹤0.01% | 356 |
|